Close Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

ShenZhen GTJA Investment Group

Investor type Private Equity Firm
Founders Dajian Cai

Overview

Unlock datapoints

Portfolio analytics

Team

Investments

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 45
Average round size
info
The average size of a deal this fund participated in
$35M
Portfolio companies 40
Rounds per year 2.14
Lead investments 11
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.11
Exits 5
Key employees 1
Stages of investment
Early Stage Venture

Areas of investment

  • Health Care
  • Biotechnology
  • Pharmaceutical
  • Medical
  • Biopharma
Summary

ShenZhen GTJA Investment Group is the famous VC, which was founded in 2001. The fund was located in Asia if to be more exact in China. The leading representative office of defined VC is situated in the Shenzhen.

The fund has exact preference in a number of founders of portfolio startups. Among the most popular fund investment industries, there are Pharmaceutical, Therapeutics. Besides, a startup needs to be aged 6-10 years to get the investment from the fund. For fund there is a match between the location of its establishment and the land of its numerous investments - China. Among the most popular portfolio startups of the fund, we may highlight Shanghai Henlius, Mabworks, Akeso Biopharma.

The typical case for the fund is to invest in rounds with 3-4 participants. Despite the ShenZhen GTJA Investment Group, startups are often financed by V Star Capital, Northern Light Venture Capital, Initial Capital. The meaningful sponsors for the fund in investment in the same round are V Star Capital, Shenzhen Capital Group, SBCVC. In the next rounds fund is usually obtained by Shenzhen Capital Group, Loyal Valley Capital, GSR Ventures.

Considering the real fund results, this VC is 53 percentage points more often commits exit comparing to other organizations. The fund is constantly included in less than 2 investment rounds annually. The important activity for fund was in 2018. The usual things for fund are deals in the range of 50 - 100 millions dollars. The average startup value when the investment from ShenZhen GTJA Investment Group is 500 millions - 1 billion dollars.

The current fund was established by Dajian Cai. Besides them, we counted 1 critical employee of this fund in our database.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of ShenZhen GTJA Investment Group:
Typical Co-investors
ShenZhen GTJA Investment Group is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after ShenZhen GTJA Investment Group:

Funds with similar focus

Funds from China
Funds with similar focus located in China:
Funds with the same geo focus
Funds with similar geography of portfolio companies:

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

TenNor Therapeutics

Biotechnology
Medical
Therapeutics
$40M30 Mar 2022 New Jersey, United States

Atom Bioscience & Pharmaceutical

Drug Discovery
Health Care
$45M05 Jan 2022 Zhenjiang, Guangdong Province, China

Cloudbreak Therapeutics

Biotechnology
Health Care
$130M01 Jan 2022 Irvine, California, United States

DK MedTech

Health Care
Medical
31 Dec 2021 Gusu District, Jiangsu, China

Boan Biotech

Biotechnology
Pharmaceutical
Product Research
Therapeutics
$13M26 Aug 2021 Yantai, Liaoning, China

VivaVision Biotech

$46M21 Apr 2021 Shanghai, China

Teligene

Biotechnology
Health Care
Pharmaceutical
$92M24 Feb 2021 Xuanwu District, Jiangsu, China

Harbour Biomed

Biopharma
Biotechnology
Pharmaceutical
$102M09 Jul 2020 China, Shanghai

Fitness
Health Care
$22M22 Jan 2020 Futian District, Guangdong Province

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent ShenZhen GTJA Investment Group?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

Wait!
You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: